Abstract
SARS-CoV-2 specific T-cells responses are essential for virus clearance. We present a novel and simple whole-blood assay allowing the detection of interferon-gamma-producing antiviral T-cells following peptide stimulation. We show that unlike neutralizing antibodies, antiviral memory T-cells persist at least 6 months in convalescent Covid-19 individuals.
Competing Interest Statement
WM, CC, SD, XL, GO, FB and KBP, are employed in bioMerieux SA, an in vitro diagnostic company.
Clinical Trial
NCT04341142
Funding Statement
This work was supported by bioMerieux SA which provided kits for this study. This research is being supported by Hospices Civils de Lyon and by Fondation des Hospices Civils de Lyon.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Comite de Protection des Personnes Sud Mediterranee, ID-RCB-2020-A00932-37 ClinicalTrial.gov NCT04341142
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data not available due to commercial restrictions
